Tags: Drug.
HybriCell is a therapeutic vaccine developed by Brazilian immunologist Jose Alexandre Barbuto. The treatment which inhibits the division of cancer cells is aimed at patients in later stages of kidney cancer or melanoma. The vaccine works by extracting certain leukocytes from the patient’s blood and merging them with cancer cells enabling the body to recognize and attack other similar cancer cells.